Inhibrx Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
28 May 24 | SellUS$10,290,000 | Brendan Eckelman | Individual | 300,000 | US$34.30 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 406 | 0.000775% |
General Public | 4,720,395 | 9.01% |
VC/PE Firms | 6,885,941 | 13.1% |
Hedge Funds | 7,150,826 | 13.6% |
Individual Insiders | 9,273,765 | 17.7% |
Institutions | 24,370,608 | 46.5% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,150,826 | US$243.9m | 0% | 0.96% | |||
4,256,104 | US$145.2m | 0% | 2.91% | |||
3,274,301 | US$111.7m | 0% | no data | |||
3,045,654 | US$103.9m | 0% | no data | |||
2,751,705 | US$93.9m | 1.33% | no data | |||
2,629,837 | US$89.7m | -44.3% | 1.23% | |||
2,417,584 | US$82.5m | 47.8% | no data | |||
2,355,553 | US$80.3m | -1.74% | no data | |||
1,861,469 | US$63.5m | -0.69% | no data | |||
1,750,387 | US$59.7m | 0% | 5.19% | |||
1,302,645 | US$44.4m | 68.5% | 2.79% | |||
1,204,252 | US$41.1m | 373% | 0.04% | |||
1,054,475 | US$36.0m | 0% | 1.86% | |||
891,220 | US$30.4m | -6.86% | 0.35% | |||
800,000 | US$27.3m | 0% | 0.19% | |||
741,591 | US$25.3m | 7.01% | 0.01% | |||
704,825 | US$24.0m | 2.54% | no data | |||
700,000 | US$23.9m | 0% | 2.76% | |||
598,257 | US$20.4m | 0% | no data | |||
542,971 | US$18.5m | 1,240% | 0.04% | |||
520,983 | US$17.8m | 96.1% | no data | |||
474,777 | US$16.2m | 320% | no data | |||
451,433 | US$15.4m | 0% | 1.3% | |||
419,778 | US$14.3m | 0% | 16.64% | |||
333,988 | US$11.4m | 0% | 1.65% |